메뉴 건너뛰기




Volumn 30, Issue 3, 2012, Pages 311-318

Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer

Author keywords

Allosteric inhibitor; Androgen receptor; Antagonist; Antiandrogens; Castration resistant prostate cancer; EPI 001; Intrinsically disordered; Small molecules

Indexed keywords

ANDROGEN RECEPTOR ANTAGONIST; ANTIANDROGEN;

EID: 84861611912     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0745-5     Document Type: Article
Times cited : (27)

References (29)
  • 4
    • 54049128964 scopus 로고    scopus 로고
    • 17alpha-Hydroxylase/17, 20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response
    • Bruno RD, Gover TD, Burger AM, Brodie AM, Njar VC (2008) 17alpha-Hydroxylase/17, 20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response. Mol Cancer Ther 7: 2828-2836.
    • (2008) Mol Cancer Ther , vol.7 , pp. 2828-2836
    • Bruno, R.D.1    Gover, T.D.2    Burger, A.M.3    Brodie, A.M.4    Njar, V.C.5
  • 5
    • 53349101498 scopus 로고    scopus 로고
    • Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17, 20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl) androsta-5,16-diene in prostate cancer
    • Vasaitis T, Belosay A, Schayowitz A, Khandelwal A, Chopra P, Gediya LK, Guo Z, Fang HB, Njar VC, Brodie AM (2008) Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17, 20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl) androsta-5, 16-diene in prostate cancer. Mol Cancer Ther 7: 2348-2357.
    • (2008) Mol Cancer Ther , vol.7 , pp. 2348-2357
    • Vasaitis, T.1    Belosay, A.2    Schayowitz, A.3    Khandelwal, A.4    Chopra, P.5    Gediya, L.K.6    Guo, Z.7    Fang, H.B.8    Njar, V.C.9    Brodie, A.M.10
  • 6
    • 0033625257 scopus 로고    scopus 로고
    • Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex
    • Waller AS, Sharrard RM, Berthon P, Maitland NJ (2000) Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex. J Mol Endocrinol 24: 339-351.
    • (2000) J Mol Endocrinol , vol.24 , pp. 339-351
    • Waller, A.S.1    Sharrard, R.M.2    Berthon, P.3    Maitland, N.J.4
  • 8
    • 0022551509 scopus 로고
    • Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer
    • Moguilewsky M, Fiet J, Tournemine C, Raynaud JP (1986) Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer. J Steroid Biochem 24: 139-146.
    • (1986) J Steroid Biochem , vol.24 , pp. 139-146
    • Moguilewsky, M.1    Fiet, J.2    Tournemine, C.3    Raynaud, J.P.4
  • 10
    • 0031594361 scopus 로고    scopus 로고
    • Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development
    • Kolvenbag GJ, Blackledge GR, Gotting-Smith K (1998) Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development. Prostate 34: 61-72.
    • (1998) Prostate , vol.34 , pp. 61-72
    • Kolvenbag, G.J.1    Blackledge, G.R.2    Gotting-Smith, K.3
  • 12
    • 27544485276 scopus 로고    scopus 로고
    • Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient
    • Yoshida T, Kinoshita H, Segawa T, Nakamura E, Inoue T, Shimizu Y, Kamoto T, Ogawa O (2005) Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient. Cancer Res 65: 9611-9616.
    • (2005) Cancer Res , vol.65 , pp. 9611-9616
    • Yoshida, T.1    Kinoshita, H.2    Segawa, T.3    Nakamura, E.4    Inoue, T.5    Shimizu, Y.6    Kamoto, T.7    Ogawa, O.8
  • 20
    • 0033583317 scopus 로고    scopus 로고
    • Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase a signal transduction pathways
    • Sadar MD (1999) Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase a signal transduction pathways. J Biol Chem 274: 7777-7783.
    • (1999) J Biol Chem , vol.274 , pp. 7777-7783
    • Sadar, M.D.1
  • 21
    • 0036510548 scopus 로고    scopus 로고
    • Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
    • Ueda T, Bruchovsky N, Sadar MD (2002) Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 277: 7076-7085.
    • (2002) J Biol Chem , vol.277 , pp. 7076-7085
    • Ueda, T.1    Bruchovsky, N.2    Sadar, M.D.3
  • 25
    • 79955719838 scopus 로고    scopus 로고
    • Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival
    • Hörnberg E, Ylitalo EB, Crnalic S, Antti H, Stattin P, Widmark A, Bergh A, Wikström P (2011) Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS One 6: e19059.
    • (2011) PLoS One , vol.6
    • Hörnberg, E.1    Ylitalo, E.B.2    Crnalic, S.3    Antti, H.4    Stattin, P.5    Widmark, A.6    Bergh, A.7    Wikström, P.8
  • 26
    • 33846609681 scopus 로고    scopus 로고
    • Androgen receptor decoy molecules block the growth of prostate cancer
    • Quayle SN, Mawji NR, Wang J, Sadar MD (2007) Androgen receptor decoy molecules block the growth of prostate cancer. Proc Natl Acad Sci USA 104: 1331-1336.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 1331-1336
    • Quayle, S.N.1    Mawji, N.R.2    Wang, J.3    Sadar, M.D.4
  • 27
    • 77955327536 scopus 로고    scopus 로고
    • Intrinsically disordered proteins are potential drug targets
    • Metallo SJ (2010) Intrinsically disordered proteins are potential drug targets. Curr Opin Chem Biol 14: 481-488.
    • (2010) Curr Opin Chem Biol , vol.14 , pp. 481-488
    • Metallo, S.J.1
  • 28
    • 58149175559 scopus 로고    scopus 로고
    • Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells
    • Sadar MD, Williams DE, Mawji NR, Patrick BO, Wikanta T, Chasanah E, Irianto HE, Soest RV, Andersen RJ (2008) Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells. Org Lett 10: 4947-4950.
    • (2008) Org Lett , vol.10 , pp. 4947-4950
    • Sadar, M.D.1    Williams, D.E.2    Mawji, N.R.3    Patrick, B.O.4    Wikanta, T.5    Chasanah, E.6    Irianto, H.E.7    Soest, R.V.8    Andersen, R.J.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.